Patent · US Active

Method of treating benign hypertrophy of the prostate

US8298132B2 · kind B2 · utility

36Cited by
99References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2008
Grant dateOct 30, 2012
Priority date
Expiry dateMar 9, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/1085
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Disclosed herein are methods of treating a patient with benign hypertrophy of the prostate, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration and attenuating a pressure change within the bladder by reversibly changing the volume of the attenuation device in response to the pressure change. In one embodiment, the attenuation device is advanced percutaneously into the bladder. In another embodiment, the attenuation device is positioned within the bladder to inhibit a decrease in compliance of the bladder wall as a consequence of the benign hypertrophy of the prostate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.